Commentary on Socias et al. (2018): Clinical research perspectives on cannabis use in opioid agonist treatment.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 30251284.
- Also identified by DOI 10.1111/add.14432 and PMC identifier 6542466.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Research is needed to determine clinical criteria as to who should be using cannabis therapeutically, how to implement therapeutic use of cannabis in opioid agonist treatment (OAT) settings optimally, and other behavioral approaches to improving OAT retention and outcomes.
Medical subject headings
- Cannabis
- Hallucinogens
- Medical Marijuana
- Opioid-Related Disorders